June 12, 2015

China part of Opdivo combo trial plans as Nasdaq-listed CBMG buys cancer vaccine
FiercePharmaAsia – June 11

Nasdaq-listed Cellular Biomedicine Group ($CBMG) has clinical trial plans that include China for cancer vaccine CD40LGVAX bought from Blackbird Bio Finance. The company paid $2.5 million in cash and $1.8 million in stock, with possible milestone payments of over $25 million, according to a press release.
The vaccine was developed by University of South Florida College of Medicine professor Scott Antonia, chair of the thoracic oncology and program leader of immuno-oncology at Moffitt Cancer Center. 

From this day: Kyle Jeanne Dalton and Adam Gray
Tampa Bay Times – June 11

Laughter isn't just curative for their patients. Massive doses of humor got Kyle Jeanne Dalton and Adam Gray through medical school. … Her father, oncologist William Dalton, former president and CEO of Moffitt Cancer Center, is the founder and CEO of its biotech subsidiary, M2Gen.

Eduardo M. Sotomayor, MD, Named Director of GW Cancer Center
ASCO Post – June 10

The George Washington University (GW) School of Medicine and Health Sciences (SMHS), the GW University Hospital, and the GW Medical Faculty Associates announced the appointment of Eduardo M. Sotomayor, MD, as the inaugural Director of the GW Cancer Center (GWCC). Prior to joining the GWCC, he served as the Scientific Director of the DeBartolo Family Personalized Medicine Institute at Moffitt Cancer Center.

Professora faz campanha para ir aos EUA fazer tratamento contra o câncer: primeira consulta está garantida
Extra – June 10

Vítima de um câncer que não reage bem à radioterapia nem à quimioterapia, ela lançou em seu Facebook, no sábado, uma campanha para arrecadar fundos e buscar ajuda no hospital Moffitt Cancer Center, na Flórida, nos EUA, especializado no tratamento.

Nivolumab Increases Response Rate vs Chemotherapy in Advanced Melanoma Progressing After Anti–CTLA-4 Treatment
ASCO Post – June 10

In a phase III trial (CheckMate 037) reported in The Lancet Oncology, Jeffrey S. Weber, MD, PhD, of the Moffitt Cancer Center, and colleagues found that treatment with the PD-1 (programmed cell death protein 1) inhibitor nivolumab (Opdivo) resulted in a significantly greater response rate vs chemotherapy as second- or later-line treatment in patients with advanced melanoma progressing after anti–CTLA-4 (cytotoxic T-lymphocyte–associated protein 4) treatment.

Chinese company buys USF vaccine
Tampa Tribune – June 9

Cellular Biomedicine Group Inc. announced today it is acquiring Blackbird Bio’s University of South Florida and Moffitt Cancer Center’s next generation vaccine to treat melanoma and Stage 4 unresectable non-small cell lung cancer. The inventor of the vaccine is Scott Antonia, M.D., Ph.D., the department chair of Thoracic Oncology and program leader of the Immuno-oncology Program at the Moffitt Cancer Center.

Cancer research firm with Moffitt ties buys exclusive rights to USF vaccine
Tampa Bay Business Journal – June 9

A cancer research firm with offices in China and Silicon Valley has bought exclusive rights to a vaccine made by University of South Florida researchers. Cellular previously added the vaccine’s inventor, Dr. Scott Antonia, to its scientific advisory board. Antonia chairs Moffitt Cancer Center’s department that researches lung cancer and leads a program that researches treating cancer through the immune system.

NBC Sports Chairman Asked NHL to Ban Playoff Beards
BoltsByTheBay.com – June 9

Another thing that Lazarus seems to be missing is how much good all of that facial hair does for the communities that call themselves home to a National Hockey League team. It seems as if he may have missed a little thing called the Beard-A-Thon that raises money for all kinds of charitable organizations like the Lightning Foundation, the Moffitt Cancer Center, and more.

Scientists use biotech to get closer to cures for diseases like cancer
WAAYTV-ABC – June 9

Amod Sarnaik, MD, Oncologist at Moffitt Cancer Center in Tampa, FL said, “To see patients, like Britta, who really had a life threatening calamity actually completely reverse to normal with the help of the cell therapy is truly phenomenal.” For Britta it’s a true masterpiece.

Green Tea May Help Fight Prostate Cancer
Prostate Cancer News Today - June 8

A team of scientists led by Nagi B. Kumar from the Moffitt Cancer Center have recently published the outcomes of a randomized clinical trial that evaluated the effectiveness and safety of the active components existent in green tea that can prevent prostate cancer in men who have pre-malignant injuries. The results were presented during the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago.

For breast cancer survivors, as the paint goes on, the pain comes off
Tampa Bay Times – June 7

Moffitt Cancer Center radiation oncologist Dr. Sarah Hoffe agrees: "As scientists, we know about the body. We know what controls the cancer. We know what regulates its growth. We know what is effective to stop it. New studies are now showing that the connection between the mind and the body is greater than we ever thought before.”

The quest for the best hamburger
Examiner.com – June 6
Don Shula’s first wife, Dorothy, died of breast cancer in 1991. The Shula family is active in breast cancer fundraising efforts, and has contributed and raised well over $1 million for the H. Lee Moffitt Cancer Center and Research Institute on the University of South Florida College of Medicine campus in Tampa.

New Drug for Lung Cancer
Ivanhoe Newswire via ABC KSAT - June 5

Ben Creelan, MD, Assistant Faculty, Medical Oncologist at Moffitt Cancer Center in Tampa, Florida told Ivanhoe, “It’s a real game changer to be able to have a treatment which works for years in some patients.”

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.